Skip to main navigation Skip to search Skip to main content

Alternative scheduling of pulsatile, high dose sunitinib efficiently suppresses tumor growth

Research output: Contribution to journalArticleAcademicpeer-review

12 Downloads (Pure)
Original languageEnglish
JournalJournal of experimental & clinical cancer research
Volume35
DOIs
Publication statusPublished - 7 Sept 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Cancer
  • Sunitinib
  • Pulsatile
  • High dose
  • Alternative scheduling
  • CAM model
  • Apoptosis
  • Autophagy
  • Tumor growth

Cite this